BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17033176)

  • 1. Aggressive CD30 large cell lymphoma after cyclosporine given for putative atopic dermatitis.
    Mougel F; Dalle S; Balme B; Houot R; Thomas L
    Dermatology; 2006; 213(3):239-41. PubMed ID: 17033176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30(+) cutaneous lymphoma in association with atopic eczema.
    Fletcher CL; Orchard GE; Hubbard V; Whittaker SJ; Edelson RL; Russell-Jones R
    Arch Dermatol; 2004 Apr; 140(4):449-54. PubMed ID: 15096373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine.
    Corazza M; Zampino MR; Montanari A; Altieri E; Virgili A
    Dermatology; 2003; 206(4):330-3. PubMed ID: 12771475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment.
    Pielop JA; Jones D; Duvic M
    Int J Dermatol; 2001 Aug; 40(8):505-11. PubMed ID: 11703521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisal.
    Noe MH; Drake A; Link BK; Liu V
    J Cutan Pathol; 2013 Aug; 40(8):714-9. PubMed ID: 23651057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous T-cell lymphoma developing in a patient on cyclosporin therapy.
    Kirby B; Owen CM; Blewitt RW; Yates VM
    J Am Acad Dermatol; 2002 Aug; 47(2 Suppl):S165-7. PubMed ID: 12140451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous CD30+ lymphoproliferative disorder in an atopic dermatitis patient on cyclosporine therapy.
    Nakamura S; Takeda K; Hashimoto Y; Mizumoto T; Ishida-Yamamoto A; Iizuka H
    Indian J Dermatol Venereol Leprol; 2011; 77(2):253. PubMed ID: 21393977
    [No Abstract]   [Full Text] [Related]  

  • 9. Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.
    Quéreux G; Renaut JJ; Peuvrel L; Knol AC; Brocard A; Dréno B
    Acta Derm Venereol; 2010 Nov; 90(6):616-20. PubMed ID: 21057746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk.
    Pomerantz RG; Campbell LS; Jukic DM; Geskin LJ
    Arch Dermatol; 2010 May; 146(5):513-6. PubMed ID: 20479299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of CD30+ nasal natural killer/T-cell lymphoma.
    Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
    Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
    Cetinözman F; Jansen PM; Willemze R
    Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis.
    Brandt C; Pavlovic V; Radbruch A; Worm M; Baumgrass R
    Allergy; 2009 Nov; 64(11):1588-96. PubMed ID: 19432936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathobiology of CD30+ cutaneous T-cell lymphomas.
    Kadin ME
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():10-7. PubMed ID: 16412208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review.
    Belloni-Fortina A; Montesco MC; Piaserico S; Bordignon M; Tona F; Feltrin G; Alaibac M
    Acta Derm Venereol; 2009; 89(1):74-7. PubMed ID: 19197546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pagetoid reticulosis with CD30 positivity and cytotoxic/suppressor cells.
    Jacyk WK; Grayson W; Dinkel JE; Requena L
    J Cutan Pathol; 2007 Aug; 34(8):644-7. PubMed ID: 17640236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD4 positive small/medium T-cell lymphoma with high proliferation index and CD30-positive large lymphoid cells.
    Zhang L; Shao H
    J Cutan Pathol; 2013 Aug; 40(8):720-4. PubMed ID: 23672694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous CD30 positive anaplastic large cell lymphoma.
    Dilnawaz M
    J Coll Physicians Surg Pak; 2010 Aug; 20(8):547-8. PubMed ID: 20688023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycosis fungoides with spontaneously regressing CD30-positive tumorous lesions.
    Woodrow SL; Basarab T; Russell Jones R
    Clin Exp Dermatol; 1996 Sep; 21(5):370-3. PubMed ID: 9136160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.